ERBB2 and breast carcinoma: Further subgroup analyses revealed a significant negative correlation between baseline TIL score and age (p < 0.05) as well as baseline CD8α levels and N-stage> 1 (p < 0.05) (Supplementary Table 4) denoting possible association between DVL2 and immune-regulatory markers of HER2+ breast cancer.